Literature DB >> 32540240

Announcing the New Definition of Health Technology Assessment.

Brian O'Rourke1, Wija Oortwijn2, Tara Schuller3.   

Abstract

Mesh：

Year:  2020        PMID： 32540240     DOI： 10.1016/j.jval.2020.05.001

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  5 in total

Review 1.  Prioritization of COVID-19 vaccination. The added value of the "VALIDATE" approach.

Authors:  Pietro Refolo; Bart Bloemen; Barbara Corsano; John Grin; Iñaki Gutierrez-Ibarluzea; Bjørn Hofmann; Wija Oortwijn; Laura Sampietro-Colom; Lars Sandman; Gert Jan van der Wilt; Dario Sacchini
Journal:  Health Policy       Date:  2022-05-20       Impact factor: 3.255

2.  Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability.

Authors:  Zsombor Zrubka; Márta Péntek; Lea Mhanna; Teebah Abu-Zahra; Mohamed Mahdi-Abid; Meriem Fgaier; Faris El-Dahiyat; Hana Al-Abdulkarim; Michael Drummond; László Gulácsi
Journal:  Pharmacoeconomics       Date:  2022-05-17       Impact factor: 4.558

3.  Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations.

Authors:  Jamie Elvidge; Ashley Summerfield; David Nicholls; Dalia Dawoud
Journal:  Value Health       Date:  2022-02-16       Impact factor: 5.101

Review 4.  Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments.

Authors:  Dario Trapani; Kiu Tay-Teo; Megan E Tesch; Felipe Roitberg; Manju Sengar; Sara C Altuna; Michael J Hassett; Armando A Genazzani; Aaron S Kesselheim; Giuseppe Curigliano
Journal:  Curr Oncol       Date:  2022-08-16       Impact factor: 3.109

5.  Possibilities of Implementing Hospital-Based Health Technology Assessment (HB-HTA) at the Level of Voivodeship Offices in Poland.

Authors:  Maciej Furman; Małgorzata Gałązka-Sobotka; Damian Marciniak; Iwona Kowalska-Bobko
Journal:  Int J Environ Res Public Health       Date:  2022-09-07       Impact factor: 4.614
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.